ISSN: 1054-3406

Journal Home

Journal Guideline

Journal of Biopharmaceutical Statistics Q2 Unclaimed

Taylor and Francis Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Biopharmaceutical Statistics is a journal indexed in SJR in Pharmacology and Statistics and Probability with an H index of 56. It has an SJR impact factor of 0,812 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,812.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2) Statistics and Probability (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,812

SJR Impact factor

56

H Index

110

Total Docs (Last Year)

203

Total Docs (3 years)

3340

Total Refs

285

Total Cites (3 years)

189

Citable Docs (3 years)

1.07

Cites/Doc (2 years)

30.36

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Journal of Pharmacological Sciences Q2
AIDS Research and Therapy Q2
Pharmacological Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

TESTING DOSE-RESPONSE RELATIONSHIPS WITH A PRIORI UNKNOWN, POSSIBLY NONMONOTONE SHAPES

STATISTICAL ANALYSIS OF THE LONG-TERM EFFECTS OF RECOMBINANT HUMAN DEOXYRIBONUCLEASE ON PULMONARY FUNCTION IN CYSTIC FIBROSIS PATIENTS

THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL

GROUP SEQUENTIAL PROCEDURES FOR REPEATED EVENTS DATA WITH FRAILTY

MULTIPLE-OBJECTIVE DESIGNS IN A DOSE-RESPONSE EXPERIMENT

CARRY-OVER EFFECTS IN BIOEQUIVALENCE STUDIES

COMBINING SUMMARIES OF BINARY OUTCOMES WITH THOSE OF CONTINUOUS OUTCOMES IN A META-ANALYSIS

A Graphical Approach for Quality Control of Oligonucleotide Array Data

Where is Health-Related Quality-of-Life Assessment in Oncology Clinical Study Heading?

PHARMACODYNAMIC ANALYSIS OF ANALGESIC CLINICAL TRIALS: NONLINEAR MIXED-EFFECTS LOGISTIC MODELS

Sensitivity Analysis for Pattern Mixture Models

STRATIFIED TESTS, STRATIFIED SLOPES, AND RANDOM EFFECTS MODELS FOR CLINICAL TRIALS WITH MISSING DATA

SHOW MORE ARTICLES

EQUIVALENCE IN TEST ASSAY METHOD COMPARISONS FOR THE REPEATED-MEASURE, MATCHED-PAIR DESIGN IN MEDICAL DEVICE STUDIES: STATISTICAL CONSIDERATIONS*

NONPARAMETRIC ANALYSIS OF COVARIANCE FOR HYPOTHESIS TESTING WITH LOGRANK AND WILCOXON SCORES AND SURVIVAL-RATE ESTIMATION IN A RANDOMIZED CLINICAL TRIAL

SOME RESULTS ON COMBINATIONS OF TWO BINARY SCREENING TESTS

ON TESTING EQUIVALENCE OF THREE POPULATIONS

Evaluating Assumptions for Least Squares Analysis Using the General Linear Model: A Guide for the Pharmaceutical Industry Statistician

ON TESTING FOR DRUG/CHEMICAL INTERACTIONS: DEFINITIONS AND INFERENCE

Effect of a Guarantee Time on Sample Size Determination for Testing the Ratio of Means from Two Lifetime Distributions

SIMPLE WAY TO ESTIMATE THE MEDIAN TIME AND COMPARE SURVIVAL DISTRIBUTIONS IN ANALGESIC TRIALS UNDER INFORMATIVE CENSORING

A MODIFIED LARGE SAMPLE APPROACH IN THE ASSESSMENT OF POPULATION BIOEQUIVALENCE

A ROBUST SUMMARIZE-REGRESS PROCEDURE FOR TISSUE-SPECIFIC PHARMACOKINETICS

Statistical Approaches in the Analysis of Gene Expression Data Derived from Bone Regeneration Specific cDNA Microarrays

CENTER-WEIGHTING ISSUES IN MULTICENTER CLINICAL TRIALS